Menu

Beam Therapeutics Inc. BEAM

Full chart Compare
Set alert

Price alert · BEAM

All alert types
26.19 USD +0.32 (+1.24%)

Nov 6, 2026, 12:14 PM EST

25.86 Day range 26.75
20.23 52-week range 38.26
YTD
-5.52%
1 year
+13.14%

Revenue & Expenses

Other Income → Expenses: $303.70MExpenses → Selling, General & Admin: $113.82MExpenses → Research & Development: $409.62MOther Operating Income → Expenses: $22.29MGross Profit → Expenses: $117.45MRevenue → Gross Profit: $117.45MRevenue → Cost of Revenue: $22.29MNet Loss → Expenses: $79.99MOther Income$303.70MOther Operating Income$22.29MGross Profit$117.45MNet Loss$79.99MCost of Revenue$22.29MExpenses$523.44MSelling, General & Admin$113.82MResearch & Development$409.62MRevenue$139.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

BEAM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
139.74M63.52M377.71M60.92M51.84M
139.74M63.52M377.71M60.92M51.84M
139.74M63.52M377.71M60.92M51.84M
523.44M479.09M554.19M399.40M444.31M
409.62M367.56M437.38M311.59M387.09M
113.82M111.53M116.81M87.81M57.22M
-383.69M-415.57M-176.49M-338.48M-392.46M
-79.99M-376.74M-132.53M-289.09M-370.64M
-79.99M-376.74M-132.53M-289.09M-370.64M
-79.99M-376.74M-132.53M-289.09M-370.64M
-79.99M-376.74M-132.53M-289.09M-370.64M
-0.81-4.58-1.72-4.13-5.77
-0.81-4.58-1.72-4.13-5.77
-0.81-4.58-1.72-4.13-5.77
-79.99M-376.70M-131.16M-285.68M-370.64M
-79.99M-376.70M-131.16M-285.68M-370.64M
98.91M82.31M77.15M70.02M64.23M
98.91M82.31M77.15M70.02M64.23M